enabl
technolog
genom
proteom
preclin
research
preclin
develop
toxicolog
formul
drug
deliveri
pharmacokinet
clinic
develop
phase
iiii
regulatori
qualiti
manufactur
postmarket
phase
iv
use
integr
antigen
microarray
approach
observ
epitopespread
autoantibodi
respons
varieti
antigen
structur
cerebrospin
fluid
csf
patient
multipl
sclerosi
ms
serum
mice
experiment
autoimmun
encephalomyel
eae
includ
previous
describ
proteinand
lipidbas
antigen
target
newli
discov
autoimmunogen
sugar
moieti
notabl
autoantibodi
specif
oligomannos
ms
patient
csf
sera
mice
eae
glycan
often
mask
sugar
moieti
belong
class
cryptic
autoantigen
determin
target
highli
express
multipl
cell
type
ms
eae
lesion
coimmun
sjlj
mice
conjug
time
eae
induct
elicit
highli
signific
level
autoantibodi
nevertheless
antiglycan
autoantibodi
respons
associ
significantli
reduc
clinic
sever
eae
potenti
cryptic
glycan
marker
target
antibodi
diagnost
therapeut
intervent
neurolog
disord
yet
explor
multipl
sclerosi
ms
complex
neurolog
disord
adapt
autoimmun
respons
thought
target
myelin
sheath
central
nervou
system
cn
patholog
inflamm
cn
white
matter
infiltr
multipl
immun
cell
includ
b
cell
macrophag
inflammatori
cell
autoreact
cell
believ
import
pathogenesi
ms
lesion
anim
model
ms
experiment
autoimmun
encephalomyel
eae
lehmann
et
al
mcrae
et
al
yu
et
al
yu
et
al
clonal
expans
b
cell
brain
tissu
presenc
oligoclon
immunoglobulin
csf
patient
ms
also
hallmark
diseas
kabat
et
al
kabat
et
al
steinman
genain
et
al
rain
et
al
hueber
et
al
evalu
autoantibodi
autoimmun
diseas
enabl
develop
new
technolog
eg
microarraybas
largescal
autoantibodi
profil
robinson
et
al
wang
et
al
kanter
et
al
beyer
et
al
robinson
et
al
develop
myelin
proteom
microarray
profil
evolut
autoantibodi
respons
eae
model
robinson
et
al
found
divers
autoantibodi
respons
increas
diseas
evolv
acut
chronic
relaps
eae
chronic
eae
associ
extens
intraand
intermolecular
epitop
spread
autoreact
bcell
respons
use
human
recombin
protein
microarray
examin
autoantibodi
profil
csf
patient
relapsingremit
ms
rrm
led
identif
panel
protein
possibl
differenti
rrm
neurolog
diseas
ond
warrant
investig
beyer
et
al
kanter
et
al
develop
lipid
array
monitor
autoantibodi
respons
lipid
present
myelin
sheath
includ
gangliosid
sulfatid
cerebrosid
sphingomyelin
total
brain
lipid
fraction
kanter
et
al
technolog
appli
monitor
lipidspecif
antibodi
respons
csf
sampl
individu
ms
control
kanter
et
al
ho
et
al
studi
show
lipidspecif
antibodi
sulfatid
sphingomyelin
oxid
lipid
csf
ms
patient
sulfatidespecif
antibodi
also
detect
sjlj
mice
acut
eae
demonstr
immun
mice
sulfatid
plu
myelin
peptid
produc
sever
diseas
cours
eae
administr
sulfatidespecif
antibodi
exacerb
eae
thu
autoimmun
respons
sulfatid
lipid
present
individu
ms
eae
may
contribut
pathogenesi
autoimmun
demyelin
carbohydr
repres
anoth
class
antigen
structur
uniqu
immunolog
properti
wang
kabat
wang
brain
myelin
sheath
tissu
contain
numer
sugar
moieti
either
form
glycolipid
glycoprotein
express
brain
carbohydr
includ
mannosyl
glycan
development
andor
differenti
regul
schachter
yuen
et
al
chai
et
al
chai
et
al
michel
campbel
breloy
et
al
breloy
et
al
pacharra
et
al
carbohydr
exist
intracellularli
part
process
protein
glycosyl
mask
sugar
moieti
matur
glycoprotein
releas
extracellularli
brook
et
al
cryptic
carbohydr
howev
potenti
immunogen
calares
et
al
wang
lu
newsomdavi
et
al
walker
et
al
exampl
virion
calares
et
al
walker
et
al
certain
tumor
newsomdavi
et
al
wang
wang
et
al
abnorm
express
nglycan
highmannos
cluster
hivinfect
subject
trkola
et
al
walker
et
al
cancer
patient
wang
wang
et
al
develop
antioligomannos
autoantibodi
respons
observ
prompt
us
ask
whether
mseaeassoci
autoantibodi
respons
also
target
class
cryptic
autoantigen
establish
versatil
bioarray
platform
integr
protein
lipid
carbohydratebas
microarray
order
facilit
identif
autoimmun
target
autoimmun
diseas
essenc
demonstr
practic
approach
construct
antigen
microarray
immobil
carbohydr
lipidsliposom
protein
molecul
nitrocelluloseco
microglass
slide
wang
et
al
wang
et
al
wang
wang
lu
bioarray
platform
use
display
autoantigen
divers
molecular
composit
includ
protein
peptid
myelin
sheath
liposom
distinct
lipid
composit
carbohydr
antigen
display
number
cryptic
glycoepitop
wang
lu
newsomdavi
et
al
wang
wang
et
al
bioarray
platform
support
quantit
measur
rel
antibodi
reactiv
rar
largepanel
antigen
thu
technic
suitabl
monitor
antigen
epitopespread
autoimmun
respons
eae
ms
method
sonic
sonic
energi
extrus
mechan
energi
use
produc
liposom
describ
wang
et
al
two
type
liposom
homoand
heteroliposom
use
studi
former
produc
via
singl
lipid
prepar
eg
phosphatidylcholin
ptc
cerebrosid
sulfatid
latter
contain
two
differ
lipid
molecul
ptc
support
display
lipidglycolipid
desir
ratio
epitop
densiti
exampl
heteroliposom
sulfatid
antigen
id
compos
sulfatid
ptc
ratio
wtwt
ie
mg
sulfatid
mg
ptc
per
ml
liposom
suspens
salin
composit
liposom
prepar
given
tabl
highprecis
microarray
robot
pixsi
cartesian
technolog
irvin
ca
use
spot
antigen
prepar
onto
glass
slide
precoat
nitrocellulos
polym
fast
slide
schleicher
schuell
keen
nh
describ
wang
antigen
prepar
appli
includ
proteinspeptid
carbohydr
liposom
variou
composit
tabl
protein
carbohydr
dissolv
phosphatebuff
salin
pb
ph
salin
nacl
respect
liposom
prepar
suspend
salin
nacl
concentr
specifi
tabl
print
triplic
spot
size
interv
center
center
print
microarray
airdri
store
room
temperatur
rt
without
desicc
applic
immedi
use
print
microarray
rins
pb
ph
volvol
tween
block
incub
slide
wtvol
bovin
serum
albumin
bsa
pb
contain
wtvol
nan
rt
min
incub
rt
antibodi
indic
titrat
wtvol
bsa
pb
contain
wtvol
nan
volvol
tween
secondari
antibodi
streptavidin
conjug
appli
microarray
stain
specifi
figur
legend
stain
slide
rins
five
time
pb
volvol
tween
airdri
rt
scan
fluoresc
signal
use
microarray
scanner
perkinelm
life
scienc
boston
follow
manufactur
manual
essenti
assess
whether
protein
synthet
peptid
carbohydr
success
print
whether
desir
epitop
antigen
determin
preserv
chip
practic
approach
incub
print
microarray
antibodi
receptor
lectin
known
react
print
substanc
illustr
figur
examin
preserv
galanthu
nivali
agglutinin
gna
specif
glycoepitop
fig
c
glycoepitop
fig
b
stain
spot
antigen
array
use
correspond
probe
demonstr
gnaepitop
present
three
glycoconjug
ie
rb
contrast
wellpreserv
one
three
ie
microarray
substrat
fluoresc
intens
valu
array
spot
background
calcul
use
scanarray
express
softwar
sa
institut
jmpgenom
softwar
packag
http
wwwjmpcom
cari
nc
use
microarray
data
standard
statist
analysi
figur
microarray
detect
shown
mean
fluoresc
intens
mfi
microspot
captur
scanarray
array
stain
gna
fig
fig
respect
analysi
microarray
raw
data
associ
visual
inspect
microarray
imag
fig
contain
triplic
spot
given
antigen
prepar
provid
evalu
reproduc
variat
antigen
microarray
technolog
figur
b
antigenspecif
igg
igm
reactiv
shown
microarray
score
transform
microarray
valu
meanbackground
data
point
figur
repres
mean
correspond
group
ie
eae
versu
normal
control
fig
ms
versu
ond
fig
rar
score
specifi
figur
defin
transform
iqr
standard
microarray
valu
iqr
function
jmpgenom
normal
array
data
set
set
interquartil
rang
iqr
ident
provid
intern
standard
data
set
statist
evalu
potenti
biomark
antigenbyantigen
analysi
varianc
anova
model
appli
obtain
statist
signific
differ
group
comparison
result
graphic
present
volcano
plot
zink
et
al
global
comparison
rar
score
group
comparison
fig
oneway
analysi
scatterplot
select
target
fig
c
volcano
plot
dot
repres
statist
weight
quantifi
differ
ms
ond
group
xaxi
normal
differ
scale
yaxi
pvalu
differ
spot
red
dash
line
repres
signatur
differ
significantli
group
anova
scatterplot
figur
c
data
point
repres
mean
triplic
determin
nomin
logist
fit
model
appli
assess
perform
serum
marker
eg
fig
upper
panel
classifi
differenti
diagnosi
ms
ond
elisa
assay
perform
describ
wang
et
al
wang
et
al
brief
elisa
microtit
plate
nunc
maxisorp
thermo
scientif
rochest
ny
coat
correspond
antigen
either
plp
incub
pretitr
mous
serum
captur
antigenspecif
igg
antibodi
reveal
tag
goat
antimous
igg
second
antibodi
lectin
immunohistochemistri
biotinyl
lectin
prepar
appli
stain
tissu
section
tissuebound
lectin
develop
streptavidinhrp
conjug
dab
substrat
lectin
pretitr
appli
studi
nonparametr
statist
test
wilcoxon
ranksum
method
use
calcul
signific
differ
among
compar
group
fig
induct
eae
immun
femal
sjl
mice
jackson
laboratori
bar
harbor
sc
plp
emulsifi
complet
freund
adjuv
cfa
day
without
addit
immun
coimmun
group
appli
immun
protocol
eae
control
group
except
inclus
immun
emuls
togeth
plp
cfa
monitor
clinic
diseas
phenomena
mice
daili
use
follow
score
system
diseas
limp
tail
hindlimb
weak
hindlimb
paralysi
hindlimb
forelimb
paralysi
death
mous
sera
taken
day
immun
weekli
immun
monitor
autoantibodi
anim
experi
approv
perform
complianc
guidelin
stanford
univers
institut
anim
care
use
committe
human
sampl
collect
use
protocol
approv
institut
review
board
karolinska
institut
stanford
univers
patient
demograph
clinic
characterist
includ
rrm
spm
ond
individu
list
tabl
level
total
igg
igm
csf
specimen
measur
elisa
microarray
studi
perform
mean
valu
total
igg
ms
group
significantli
higher
ond
group
test
p
level
total
igm
ms
group
differ
ond
group
test
p
experi
panel
antigen
divers
molecular
structur
spot
bioarray
substrat
tabl
protein
peptid
myelin
sheath
n
lipidsliposom
n
carbohydr
antigen
n
panel
glycoconjug
display
cryptic
glycoepitop
includ
highmannoseclust
includ
array
use
array
analyz
serum
sampl
sjlj
mice
immun
myelin
proteolipid
protein
peptid
plp
kanteret
al
autoantibodi
use
group
agematch
sjlj
mice
control
figur
show
repres
microarray
imag
captur
antigenspecif
igg
upper
igm
bottom
shown
mous
eae
right
column
agematch
control
sjlj
mous
left
column
visual
inspect
microarray
imag
identifi
four
proteinpeptid
probe
plp
myelin
oligodendrocyt
glycoprotein
mog
two
prepar
myelin
basic
protein
mbp
mark
red
detect
markedli
increas
autoantibodi
igg
igm
isotyp
two
lipid
probe
sulfatid
dimyristoylphosphatidylserin
dmp
yellow
two
white
captur
signific
amount
igm
igg
sampl
panel
mice
eae
quantit
comparison
two
group
conduct
examin
signific
observ
figur
show
overlay
plot
antibodi
profil
two
group
level
igg
igm
antibodi
shown
mean
ig
score
group
antibodi
valu
eae
group
n
color
red
control
n
blue
overal
antibodi
profil
two
group
appear
similar
except
specif
probe
autoantibodi
myelin
protein
figur
illustr
result
oneway
anova
four
marker
includ
ptc
sulfatid
similar
brain
sulfatid
two
captur
increas
amount
autoantibodi
igm
isotyp
eae
group
compar
control
group
nm
howev
differ
two
group
induct
igg
autoantibodi
marker
result
demonstr
plpprime
induc
autoantibodi
igg
igm
isotyp
myelin
protein
plp
mog
mbp
select
elicit
igm
respons
number
lipid
carbohydr
antigen
latter
includ
autoantibodi
brain
sulfatid
dmp
previous
recogn
use
pvdfimmobil
lipid
array
kanter
et
al
ho
et
al
carbohydratebas
novel
marker
next
examin
whether
carbohydr
lipid
detect
antibodi
eae
model
might
also
detect
autoantibodi
csf
ms
patient
ond
control
subject
purpos
creat
microarray
display
panel
carbohydr
lipid
probe
focus
investig
nonprotein
marker
carbohydr
antigen
display
nglycan
cryptic
glycoepitop
eg
agor
asor
mannos
cluster
wang
wang
newsomdavi
et
al
wang
et
al
includ
microarray
spot
fig
figur
b
show
overlay
plot
antibodi
profil
two
group
color
needl
link
pair
group
mean
provid
global
comparison
antibodi
profil
ms
group
red
circl
ond
group
blue
cross
comparison
reveal
global
differ
antibodi
profil
two
group
specif
microarray
score
csfantibodi
activ
ms
group
gener
higher
seen
csf
ond
subject
includ
antilipid
antibodi
right
previous
report
also
anticarbohydr
antibodi
left
observ
may
reflect
fact
total
ig
concentr
csf
ms
patient
higher
csf
ond
subject
one
hallmark
ms
kabat
et
al
kabat
et
al
steinman
rain
et
al
hueber
et
al
examin
whether
select
enrich
antigenspecif
antibodi
csf
ms
patient
reason
identifi
antibodi
might
provid
clue
pinpoint
key
autoimmunogen
target
ms
purpos
introduc
approach
establish
rar
score
microarray
detect
seek
target
captur
antibodi
signal
higher
rar
score
ms
patient
specif
normal
microarray
data
set
set
iqr
ident
use
jmpgenom
softwar
packag
statist
oper
effect
quench
variat
seen
subject
due
variabl
antibodi
concentr
csf
two
group
illustr
similar
igrar
profil
igg
igm
antibodi
activ
fig
howev
number
probe
show
higher
iggrar
score
ms
group
ond
control
includ
two
three
glucos
polysaccharid
dextran
bactoagar
extract
antigen
fig
conduct
anova
analysi
identifi
antibodi
signatur
differ
ms
ond
group
base
critic
bonferroni
test
figur
show
result
volcano
plot
zink
et
al
wherein
point
repres
statist
weight
quantifi
differ
ms
ond
group
xaxi
normal
differ
scale
rar
ond
rar
ms
yaxi
pvalu
differ
antibodi
signatur
captur
assay
fig
two
cutoff
line
pvalu
highli
signific
differenti
ms
ond
result
oneway
anova
two
cluster
shown
figur
logist
regress
analysi
suggest
csf
autoantibodi
signatur
highli
signific
differenti
diagnosi
ms
ond
produc
area
roc
curv
valu
respect
antibodi
signatur
weight
cutoff
line
fig
includ
four
signatur
variabl
higher
ms
group
ond
group
p
p
p
bactoagarigg
p
base
bonferroni
test
recognit
two
highmannos
cluster
hypothes
mannosyl
glycan
may
aberrantli
express
vivo
mseae
subject
exposur
cryptic
sugar
moieti
trigger
specif
autoantibodi
respons
therefor
examin
msand
eaeaffect
cn
tissu
determin
whether
abnorm
express
highmannos
clusterrel
carbohydr
appli
lectin
known
specif
monitor
express
variou
nglycan
complex
carbohydr
ms
normal
control
brain
tissu
sampl
spinal
cord
eae
mice
fig
follow
three
lectin
appli
gna
specif
mannoseclust
ii
phaseolu
vulgarisl
phal
specif
triii
mii
cluster
iii
sambucu
nigra
agglutinin
snai
recogn
link
residu
result
studi
gna
normal
human
cerebr
cortex
fig
cytoplasm
neuron
red
arrow
stain
inflammatori
ms
lesion
gna
stain
number
cell
type
includ
cell
morpholog
appear
macrophag
reactiv
astrocyt
small
red
arrow
dystroph
axon
also
strongli
posit
upper
right
corner
thick
red
arrow
acut
inflammatori
eae
lesion
gna
stain
mani
dystroph
axon
eg
thick
red
arrow
macrophag
debri
eg
thin
red
arrow
posit
stain
spinal
cord
control
mice
data
shown
b
phal
normal
human
cerebr
cortex
phal
stain
neg
activ
ms
lesion
diffus
weak
phal
stain
eae
lesion
phal
stain
neg
c
sna
sna
demonstr
posit
stain
capillari
endotheli
cell
normal
human
cerebr
cortex
red
arrow
activ
ms
lesion
sna
select
stain
cell
morpholog
consist
reactiv
microglia
eg
thick
red
arrow
well
endotheli
cell
small
red
arrow
eae
lesion
sna
stain
macrophag
debri
endotheli
cell
red
arrow
normal
mice
sna
stain
limit
endotheli
cell
data
shown
taken
togeth
observ
express
highmannos
glycan
defin
gna
restrict
cortic
neuron
normal
human
brain
tissu
highli
broadli
distribut
multipl
cell
type
tissu
repres
ms
eae
lesion
ii
trimii
chain
detect
phal
expos
lectin
stain
normal
brain
tissu
minim
express
activ
ms
lesion
iii
epitop
sna
present
blood
vessel
red
blood
cell
normal
brain
tissu
aberrantli
express
ms
eae
lesion
thu
repertoir
aberr
carbohydr
ms
eae
limit
highmannos
nglycan
structur
indic
alter
express
sna
epitop
lesion
next
determin
whether
carbohydr
target
could
alter
cours
eae
use
immunogen
codeliv
myelin
peptid
emulsifi
cfa
kanter
et
al
took
approach
examin
vivo
effect
lipid
marker
sulfatid
identifi
ms
eaeassoci
autoantigen
lipid
array
analysi
kanter
et
al
demonstr
coimmun
mice
sulfatid
plu
myelin
peptid
result
sever
diseas
cours
administr
antisulfatid
antibodi
exacerb
eae
present
studi
coimmun
sjl
mice
togeth
myelin
peptid
plp
highmannoseclust
immunogen
immun
strategi
elicit
antibodi
target
oligomannos
antigen
anticarbohydr
antibodi
pathogen
induct
antibodi
worsen
diseas
cours
vivo
valid
experi
conduct
twice
similar
outcom
first
test
mice
use
experiment
group
plpcfa
control
group
second
test
employ
mice
group
fig
illustr
eae
score
curv
fig
activ
immun
plu
plp
worsen
rather
improv
cours
eae
although
elicit
hightit
antiplp
igg
antibodi
well
antioligomannos
igg
antibodi
fig
although
differ
titer
antiplp
igg
antibodi
plp
control
group
fig
right
panel
latter
elicit
markedli
increas
antibodi
determin
glycanspecif
elisa
assay
fig
left
panel
appli
integr
protein
lipid
carbohydr
microarray
character
autoantibodi
respons
plpinduc
eae
model
sjlj
mice
found
eaeassoci
autoantibodi
profil
character
domin
igg
antibodi
direct
myelin
protein
broader
spectrum
igm
antibodi
target
lipidand
carbohydratebas
autoantigen
igm
antibodi
specif
brain
sulfatid
dmp
previous
recogn
kanter
et
al
confirm
use
integr
multicompon
microarray
fig
addit
detect
anticarbohydr
autoantibodi
specif
highmannos
type
nglycan
oligomannos
similar
antisulfatid
igm
igg
antioligomannos
antibodi
detect
panel
eae
mice
fig
note
antioligomannos
antibodi
detect
eae
also
select
enrich
csf
ms
patient
fig
specif
antimannos
cluster
autoantibodi
detect
eae
strikingli
similar
csf
ms
patient
specif
eaederiv
msd
eriv
antioligomannos
antibodi
similarli
reactiv
two
illustr
figur
former
conjug
latter
conjug
bind
profil
similar
lectin
gna
fig
differ
bind
profil
human
monoclon
antibodi
fig
microarray
assay
antibodi
well
character
unusu
domainexchang
recogn
man
moieti
dens
cluster
configur
highmannos
type
nglycan
display
outer
domain
hiv
glycoprotein
calares
et
al
microarray
highli
reactiv
cluster
ncluster
configur
weakli
reactiv
nconfigur
fig
contrast
lectin
gna
strongli
equal
reactiv
two
oligomannoseconjug
fig
thu
bind
specif
ms
eaeassoci
antioligomannos
autoantibodi
overlap
bind
profil
gna
examin
whether
gnadefin
mannosyl
glycan
marker
express
cn
normal
brain
tissu
fig
gna
select
stain
cytoplasm
compart
human
cortic
neuron
neg
area
contrast
gna
highli
broadli
reactiv
multipl
cell
type
ms
lesion
includ
macrophag
reactiv
astrocyt
dystroph
axon
fig
similarli
lectin
stain
mani
dystroph
axon
macrophag
debri
spinal
cord
lesion
mice
eae
fig
thu
gnadefin
mannosyl
glycan
marker
aberrantli
express
inflammatorydemyelin
cn
lesion
eae
model
provid
uniqu
experiment
condit
examin
potenti
immunogen
highmannoseclust
vivo
specif
test
conjug
capac
elicit
acquir
immun
respons
oligomannos
epitop
found
singl
sc
inject
plpcfa
emuls
contain
elicit
highli
signific
antioligomannos
igg
antibodi
fig
thu
highmannoseclusterconjug
immunogen
vivo
experiment
condit
effect
anticarbohydr
immun
may
illumin
develop
novel
vaccin
strategi
target
glycan
marker
virus
calares
et
al
wang
lu
astronomo
et
al
certain
human
cancer
hakomori
newsomdavi
et
al
wang
moreov
observ
induct
igg
antioligomannos
respons
associ
significantli
reduc
clinic
sign
eae
fig
find
contrast
result
observ
follow
administr
sulfatid
experiment
set
sever
diseas
cours
observ
kanter
et
al
investig
elucid
physiolog
andor
patholog
role
antimannos
cluster
autoantibodi
whether
autoantibodi
play
januslik
oppos
role
autoimmun
brain
inflamm
han
et
al
consider
exampl
gnalik
autoantibodi
bind
dystroph
axon
cell
debri
mseae
lesion
fig
would
benefici
contribut
effect
clearanc
myelin
debri
expos
cryptic
glycoepitop
explor
antiglycan
antibodi
potenti
serum
biomark
differenti
diagnosi
prognosi
neurolog
disord
activ
research
area
willison
willison
yuki
schwarz
et
al
schwarz
et
al
lolli
et
al
brettschneid
et
al
notabl
human
serum
igm
antibodi
specif
number
glucosyl
target
investig
ms
diagnosi
prognosi
schwarz
et
al
schwarz
et
al
brettschneid
et
al
includ
glc
glc
glc
glc
glc
glc
glc
glc
present
studi
test
panel
glucos
polysaccharid
includ
dextran
prepar
wang
kabat
dextran
predominantli
display
intern
chain
epitop
ie
repetit
unit
glc
glc
n
linear
chain
heavili
branch
display
mani
termin
nonreduc
end
epitop
glc
glc
n
character
linkag
may
present
glc
glc
moieti
intern
termin
epitop
howev
pilot
studi
limit
sampl
size
difficult
conclud
whether
antibodi
polysaccharid
significantli
enrich
csf
ms
subject
fig
addit
glucos
polysaccharid
observ
csfenrich
antibactoagar
igg
antibodi
csf
ms
subject
bactoagar
prepar
extract
pyruvyl
galatosyl
polysaccharid
epitop
also
present
microbi
polysaccharid
eg
klebsiella
kabat
et
al
antidextran
antibactoagar
antibodi
often
present
human
circul
kabat
berg
wang
et
al
detect
common
anticarbohydr
antibodi
csf
blood
may
util
monitor
function
integr
bloodbrain
barrier
find
must
valid
larger
cohort
ms
ond
subject
share
carbohydr
determin
microb
brain
tissu
manosyl
moieti
repres
yet
anoth
pathway
microbiom
autoimmun
intersect
neuroinflammatori
diseas
state
wang
et
al
wang
lu
yuki
et
al
shahrizaila
yuki
ogawa
et
al
carbohydr
microarray
analysi
oligomannosyl
antigen
express
gnalik
glycoepitop
mannoseclustercontain
microarray
stain
biotinyl
gna
respect
former
reveal
alexa
tag
goat
antihuman
iggfcspecif
antibodi
develop
conjug
microarray
imag
stain
either
gna
b
cluster
configur
three
microarray
detect
shown
mean
fluoresc
intens
mfi
microspot
captur
scanarray
array
stain
gna
c
respect
result
compar
use
overlay
plot
mfi
stain
signal
circl
versu
local
background
surround
antigen
microarray
cross
c
color
figur
view
onlin
issu
avail
wileyonlinelibrarycom
epitop
spread
broad
rang
protein
peptid
lipid
carbohydr
serum
mice
eae
detect
integr
microarray
panel
antigen
structur
tabl
spot
versatil
bioarray
substrat
triplic
dilut
gener
total
microspot
antigen
per
array
platform
support
detect
uniqu
antibodi
signatur
includ
iggand
igmantibodi
signatur
array
stain
serum
sampl
dilut
mous
eae
right
agematch
control
sjl
mous
left
captur
igg
upper
array
imag
stain
antiigg
antibodi
conjug
captur
igm
array
bottom
reveal
rpetag
antiigm
secondari
antibodi
array
locat
myelin
protein
plp
mog
mbp
lipid
liposom
sulfatid
ceramid
dmp
highmannoseclust
box
b
level
igg
igm
antibodi
shown
mean
ig
score
group
present
separ
overlay
plot
ig
valu
eae
group
n
mark
circl
control
n
cross
microarray
score
antigenspecif
igg
igm
reactiv
shown
microarray
score
transform
meanbackground
valu
microarray
detect
c
result
statist
analysi
four
probe
includ
two
lipid
antigen
ptc
sulfatid
two
mannoseclust
eae
mice
examin
experi
induc
immun
sjlj
mice
myelin
plp
describ
kanter
et
al
color
figur
view
onlin
issu
avail
wileyonlinelibrarycom
integr
lipidcarbohydr
array
recogn
global
elev
antigenspecif
antibodi
csf
ms
patient
compar
detect
ond
csf
csf
sampl
ms
rrm
spm
ond
subject
character
use
microarray
spot
lipid
carbohydr
antigen
prepar
spot
triplic
dilut
illustr
overlay
plot
ad
microarray
support
detect
uniqu
antibodi
signatur
includ
igg
c
igm
b
signatur
antihuman
igg
igm
secondari
antibodi
use
reveal
antigenspecif
antibodi
detect
microarray
captur
igg
stain
antihuman
igg
antibodi
conjug
captur
igm
array
reveal
biotinyl
antihuman
igm
secondari
antibodi
develop
conjug
microarray
data
set
b
process
describ
legend
figur
illustr
microarray
score
c
microarray
data
set
process
use
jmpgenom
produc
rar
score
result
present
overlay
plot
mean
microarray
score
group
color
needl
link
group
mean
pair
score
provid
global
comparison
antibodi
profil
ms
group
circl
ond
cross
rar
score
rarrel
antibodi
reactiv
valu
transform
iqrstandard
microarray
valu
meanbackground
antigen
given
concentr
mean
valu
triplic
array
detect
calcul
color
figur
view
onlin
issu
avail
wileyonlinelibrarycom
msassoci
autoantibodi
csf
sampl
target
highmannos
cluster
core
nglycan
volcano
plot
analysi
rar
score
antibodi
signatur
volcano
plot
point
repres
biolog
uniqu
featur
captur
microarray
ie
normal
differ
specif
antibodi
signatur
rar
ms
rar
ond
xaxi
normal
differ
scale
yaxi
pvalu
weight
level
signific
differ
point
dash
line
cutoff
level
repres
signatur
differ
significantli
group
base
bonferroni
test
two
signatur
identifi
critic
statist
test
highli
signific
marker
b
c
oneway
analysi
perform
compar
group
mean
among
select
carbohydr
antigen
list
panel
point
panel
repres
mean
valu
rar
score
triplic
array
detect
subject
mean
shown
bar
standard
deviat
diamond
around
mean
valu
comparison
circl
student
test
appear
right
mean
diamond
illustr
signific
differ
among
mean
graphic
show
intersect
circl
allow
visual
inspect
signific
differ
circl
intersect
less
signific
differ
vice
versa
color
figur
view
onlin
issu
avail
wileyonlinelibrarycom
lectin
gna
phal
sna
histochemistri
human
brain
tissu
normal
ms
mous
spinal
cord
eae
lesion
cn
tissu
stain
biotinyl
lectin
develop
streptavidinhrp
conjug
dab
substrat
lectin
pretitr
appli
tissu
stain
column
b
c
stain
lectin
gna
phal
sna
respect
normal
ms
eae
carbohydr
recogn
lectin
indic
column
induct
igg
antibodi
coimmun
mannoseclust
pathogen
myelin
peptid
worsen
cours
eae
overlay
plot
eae
score
group
n
vehicl
control
group
n
group
coimmun
sjl
mice
plp
emulsifi
cfa
vehicl
control
group
immun
plp
plu
cfa
without
addit
immunogen
point
repres
mean
sem
statist
test
mannwhitney
test
use
calcul
signific
differ
two
group
time
point
illustr
signific
differ
p
mark
graph
b
igg
c
antiplp
igg
respons
analys
elisa
serum
specimen
eae
experi
fig
titrat
antigenspecif
elisa
preliminari
experi
appli
dilut
elisa
detect
antigenspecif
igg
b
elisa
plate
coat
conjug
detect
igg
day
postimmun
plp
c
elisa
plate
coat
plp
detect
plpspecif
igg
serum
specimen
serum
antibodi
specif
carrier
bsa
day
preimmun
day
postimmun
preexist
antiplp
day
sera
detect
sensit
elisa
od
nm
oneway
anova
perform
compar
elisa
result
obtain
group
nonparametr
statist
test
wilcoxon
ranksum
method
appli
calcul
signific
differ
compar
group
immunomodulatori
treatment
taken
patient
time
sampl
spm
secondari
progress
multipl
sclerosi
rrm
relapsingremit
multipl
sclerosi
